Drugmaker AstraZeneca is moving its experimental prostate cancer treatment into Phase III clinical trials. The medication--called ZD4054--is designed to treat men whose cancer appears to be resistant to hormone therapy. The Phase III trial is expected to begin later this year.
Read moreWe here at Health Central try to offer you up-to-date health news you can use. Well we recently heard about a new online tool created... Read more »
As everyone reading my blog—and this website—knows, the PSA test has not been the best diagnostic test ever invented. It can mislead... Read more »
A fascinating study out of the National Cancer Institute has significant implications for men at risk for prostate cancer and men with... Read more »
Prostate cancer is the sixth most common cancer in the world and the second leading cause of cancer death in American men. Almost a quarter... Read more »
One out of six men in the US will be diagnosed with prostate cancer during his lifetime - that means a lot of men with residual erectile... Read more »
Scientists in Illinois say they've developed a cancer drug that is 200 times more effective than similar medications. Zoledronate is a... Read more »
Researchers have developed an experimental drug that may slow advanced prostate cancer. The drug--called MDV3100--blocked tumor growth in 40 percent... Read more »
According to recent clinical trials, the medication abiraterone shows promise in treating prostate cancer tumors that have not been stunted by... Read more »
Methods currently used to ID the aggressiveness of prostate cancer can find false positives, but researchers say a new urine test may change that.... Read more »
This is a study to assess if men with metastatic prostate cancer who are undergoing androgen deprivation treatments respond to the experimental med... Read more »